Serge G. Gauthier

Serge G. Gauthier

Verdun, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 330 publications

Using CA1 rather than the whole hippocampus to capture tau-PET Braak stage II.

Using CA1 rather than the whole hippocampus to capture tau-PET Braak stage II.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 12, 2026

Predicting continuous amyloid PET levels with CSF and plasma brain-derived p-tau217.

Predicting continuous amyloid PET levels with CSF and plasma brain-derived p-tau217.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 11, 2026

Posterior cortical atrophy and logopenic variant primary progressive aphasia are more specific for Alzheimer's disease pathology than probable Alzheimer's disease.

Posterior cortical atrophy and logopenic variant primary progressive aphasia are more specific for Alzheimer's disease pathology than probable Alzheimer's disease.

Journal: Brain communications

Published: March 13, 2026

Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areas.

Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areas.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: February 09, 2026

Association of Cortical Free Water With Brain Tau Tangle Load in the Alzheimer Disease Continuum.

Association of Cortical Free Water With Brain Tau Tangle Load in the Alzheimer Disease Continuum.

Journal: Neurology

Published: February 06, 2026

Elevation in network dynamics amplifies amyloid-dependent tau pathology.

Elevation in network dynamics amplifies amyloid-dependent tau pathology.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 01, 2025

Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials.

Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials.

Journal: CNS drugs

Published: November 10, 2025

Estimated prevalence of underdiagnosed dementia in a multiethnic community-based study.

Estimated prevalence of underdiagnosed dementia in a multiethnic community-based study.

Journal: The journal of prevention of Alzheimer's disease

Published: November 06, 2025

Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data.

Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data.

Journal: The journal of prevention of Alzheimer's disease

Published: October 07, 2025

Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease.

Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease.

Journal: The journal of prevention of Alzheimer's disease

Published: October 01, 2025

Implication for Clinical Trials From Longitudinal Tau-PET Accumulation Across Biological Alzheimer Disease Stages.

Implication for Clinical Trials From Longitudinal Tau-PET Accumulation Across Biological Alzheimer Disease Stages.

Journal: Neurology

Published: September 23, 2025

Aβ- and tau-associated neuroinflammatory signatures in Alzheimer's disease.

Aβ- and tau-associated neuroinflammatory signatures in Alzheimer's disease.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: September 19, 2025

Showing 1-12 of 330

Last Updated: 09/26/2026